Geneticure Inc. Granted New U.S. Patent for Genetic Test to Predict Response in Renal Denervation for Hypertension
ROCHESTER, Minn., July 10, 2025--(BUSINESS WIRE)--Geneticure Inc., a leader in precision medicine for cardiovascular disease, announced today that the United States Patent and Trademark Office has granted U.S. Patent No. 12,351,873, for a Genetic-Based Weighted Algorithm Model for Predicting Response to Renal Denervation. This groundbreaking patent protects Geneticure's proprietary method of using a patient's genetic profile to predict their likelihood of benefiting from renal denervation — a minimally invasive procedure used to treat hypertension.
"Renal denervation has demonstrated the ability to reduce blood pressure in certain patients, with other's experiencing no change or an increase in blood pressure post-denervation." said Scott Snyder, CEO of Geneticure. "Prior to Geneticure's research, a reliable method of predicting the response had not yet emerged and regardless of the denervation method, the changes in blood pressure have been variable across patient populations. Our technology has proven to identify the individuals most likely to respond, enabling more targeted use of this emerging therapy with increased prospects for adoption and payer coverage."
The patented method leverages specific genetic markers combined with a proprietary weighted algorithm to determine responsiveness to renal denervation, enabling physicians to make informed treatment decisions beyond traditional risk-factor assessments.
This newly issued patent expands Geneticure's growing intellectual property portfolio in the field of pharmacogenomics and device response prediction, further positioning the company at the forefront of personalized hypertension management.
More on Geneticure for Renal Denervation:
https://www.slideshare.net/slideshow/genetic-scoring-related-to-renal-denervation-response/254331538
https://geneticure.com/rdn/
About Geneticure
Geneticure Inc. is an Integrated Computational Genomic medicine company focused on eliminating the trial-and-error approach to treating chronic diseases. By integrating a patient's genetic information with physiologic insights, Geneticure provides physicians with actionable tools to optimize therapy selection and improve outcomes. The company's flagship offerings include genetic tests that predict response to common hypertension medications and now, response to renal denervation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250710656704/en/
Contacts
Media Contact: Scott SnyderChief Executive OfficerGeneticure Inc.info@geneticure.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
US nuclear weapons agency breached in Microsoft SharePoint hack, Bloomberg News reports
(Reuters) -U.S. National Nuclear Security Administration was among those breached by a hack of Microsoft's SharePoint document management software, Bloomberg News reported on Tuesday, citing a person with knowledge of the matter. Bloomberg reported that no sensitive or classified information is known to have been compromised in the attack on the National Nuclear Security Administration, the agency responsible for maintaining and designing the nation's cache of nuclear weapons. Reuters could not immediately verify the report. The U.S. Energy Department, U.S. Cybersecurity and Infrastructure Security Agency, and Microsoft did not immediately respond to request for comments from Reuters. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Bullish retail traders are the biggest force behind the stock market's latest rally to all-time highs
The stock market's latest push to all-time highs has largely been driven by dip-buying retail investors. Barclays said the 26% climb since early April was spurred by individuals rather than institutions. Retail traders bought $270 billion in stocks in the first half, according to a JPMorgan analysis. You can thank the little guys for pushing the stock market to its latest all-time high. Retail traders have been on a dip-buying frenzy since President Donald Trump announced his tariffs in April. Analysts at Barclays estimated that retail traders ploughed around $50 billion into global stocks in the last month. Stock-buying among institutional investors has paled by comparison, with hedge fund re-risking remaining "modest" and their long positions in US stocks remaining below the long-term median, the bank said on Tuesday. The data suggests retail investors are largely driving the red-hot rally to record highs. The S&P 500, which weathered a historic sell-off in early April, is now up 26% from its low on April 8. "In retrospect, 'Liberation day' ushered in historic retail-driven 'buy-the-dip,'" analysts wrote. Wall Street has been keeping a close eye on the swelling appetite for US stocks among retail traders. In a note to clients this month, JPMorgan estimated that retail investors purchased a net $270 billion worth of stocks over the first half of the year. The bank added that it sees retail traders buying another $360 billion worth of stocks through the end of 2025, which could push the S&P 500 higher by 5%-10%. A separate analysis from Vanda Research estimated that cumulative retail net purchases of stocks and exchange-traded funds hit $155.3 billion in the first six months. That's the largest inflow over the first half of the year in at least the last 10 years, the firm said in a note. "Portfolio health is likely a strong factor behind elevated retail participation so far in Q2," Vanda Research's Ianchini wrote in a separate note last week. "That, plus a successful dip-buying effort in April, and a still-OK labor market may help explain why mom-and-pop traders remain a resilient source of demand for equities in 2025." According to an eToro survey conducted in May, 61% of retail investors say they're dip-buyers, with the majority buying into the market once it drops 18% or more. In particular, younger traders said they were most likely to change their investing strategy when the market was turbulent, with 91% of Gen Z investors and 87% of millennials saying that they react when volatility increases. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
26 minutes ago
- Bloomberg
Chicago CFO Says Property Tax Hike Likely in 2026 Budget Package
Chicago Chief Financial Officer Jill Jaworski said the city will likely seek to raise property taxes to address next year's budget deficit. 'It is likely that that will be part of the package,' Jaworski said in an interview at Bloomberg's New Voices event in Chicago on Tuesday. 'We haven't rolled out the full package yet, but the package is going to include cuts, and it is going to include proposals for increasing our revenues.'
